Determinants of Serum Total and Free Testosterone Levels in Women over the Age of 65 Years
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
CONTEXT: Little is known about testosterone (T) levels and their determinants in women of late postmenopausal age. OBJECTIVE: We describe levels of total and free T and selected factors that influence these levels in a random sample of older women. DESIGN: Levels of serum total T and free T by microdialysis were measured using ultrasensitive assays in 347 community-dwelling women aged 65-98 yr enrolled in the Cardiovascular Health Study. Cross-sectional analyses were performed to define factors associated with total and free T levels. RESULTS: In adjusted models: 1) total T levels declined with age until 80, whereas free T levels did not vary by age; 2) women with bilateral oophorectomy had 23% lower total T and 16% lower free T levels than those with at least one intact ovary; 3) oral estrogen users had total and free T levels that were 47% lower than never users; 4) obese women had 47% higher total T and 20% higher free T levels, and overweight women had 24% higher total T and 14% higher free T levels, than normal weight women; and 5) free T levels were 51% higher in black women. Corticosteroid users had 75% lower total T and 43% lower free T levels than nonusers. CONCLUSIONS: Bilateral oophorectomy, estrogen use, corticosteroid use, and low body mass index are independent risk factors for lower T levels in women aged 65 yr and over. Although highly prevalent in women of this age, the physiological significance of low T levels in late postmenopausal women requires further investigation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Testosterone concentrations appear to be maintained in women beyond the age of 65 years, but whether this confers a benefit is yet to be understood 3,5 (Level IIB).”
From Global Consensus Position Statement on the Use of Testosterone Therapy for Women (2019) · cites this paper as [5]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Critical Evaluation of Simple Methods for the Estimation of Free Testosterone in Serum
Vermeulen, A., Verdonck, L., & Kaufman, J. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6079 · Cited by 3,824 · cited 1×
“Our free T levels were measured via equilibrium dialysis, considered the gold standard for free T measurement (5, 34).”
MethodThe Cardiovascular Health Study: design and rationale.
Fried, L. P., Borhani, N. O., Enright, P., Furberg, C. D., Gardin, J. M., Kronmal, R. A., Kuller, L. H., Manolio, T. A., Mittelmark, M. B., Newman, A., et al. (1991) · Annals of Epidemiology · doi:10.1016/1047-2797(91)90005-w · Cited by 3,652
Self-citationORENTREICH, N., BRIND, J. L., RIZER, R. L., & VOGELMAN, J. H. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-59-3-551 · Cited by 1,349
Androgen Levels in Adult Females: Changes with Age, Menopause, and Oophorectomy
Davison, S. L., Bell, R., Donath, S., Montalto, J. G., & Davis, S. R. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0212 · Cited by 998 · cited 4×
“In 684 women aged 50–89 yr enrolled in the Rancho Bernardo Study, levels of total and bioavailable T were 40% lower in women with bilateral oophorectomy than in those with intact ovaries (8), a finding recently confirmed in another crosssectional study with women up to age 75 yr (9).”
BackgroundMethodResultInfluentialTransdermal testosterone treatment in women with impaired sexual function after oophorectomy.
Shifren, J. L., Braunstein, G. D., Simon, J. A., Casson, P. R., Buster, J. E., Redmond, G. P., Burki, R. E., Ginsburg, E. S., Rosen, R. C., Leiblum, S. R., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009073431002 · Cited by 954
Laaksonen, D. E., Niskanen, L., Punnonen, K., Nyyssönen, K., Tuomainen, T.-P., Valkonen, V.-P., Salonen, R., & Salonen, J. T. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1036 · Cited by 920 · cited 1×
“The direct relationship between BMI and T levels in women contrasts strikingly with that in men, in which BMI is inversely correlated with total T levels (33).”
ResultHuman growth hormone and human aging
CORPAS, E., HARMAN, S. M., & BLACKMAN, M. R. (1993) · Endocrine Reviews · doi:10.1210/edrv-14-1-20 · Cited by 911
Self-citationCirculating Androgen Levels and Self-reported Sexual Function in Women
Davis, S. R. (2005) · JAMA · doi:10.1001/jama.294.1.91 · Cited by 510
Braunstein, G. D., Sundwall, D. A., Katz, M., Shifren, J. L., Buster, J. E., Simon, J. A., Bachman, G., Aguirre, O. A., Lucas, J. D., Rodenberg, C., et al. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.14.1582 · Cited by 458
Bachmann, G., Bancroft, J., Braunstein, G., Burger, H., Davis, S., Dennerstein, L., Goldstein, I., Guay, A., Leiblum, S., Lobo, R., et al. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(02)02969-2 · Cited by 444
Laboratory methods and quality assurance in the Cardiovascular Health Study
Cushman, M., Cornell, E. S., Howard, P. R., Bovill, E. G., & Tracy, R. P. (1995) · Clinical Chemistry · doi:10.1093/clinchem/41.2.264 · Cited by 439 · cited 1×
“Blood was drawn in the morning after a 12-h fast and serum was frozen in 70 C freezers for future investigations (12).”
MethodBurger, H. G., Dudley, E. C., Cui, J., Dennerstein, L., & Hopper, J. L. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.8.6740 · Cited by 439 · cited 1×
“When we replaced age with time since menopause, we saw no relationship between this alternate time axis and total or free T levels, consistent with findings from other studies suggesting no impact of menopause on T production (8, 9, 18).”
ResultOvarian and adrenal contribution to peripheral androgens during the menstrual cycle
ABRAHAM, G. E. (1974) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-39-2-340 · Cited by 436
Testosterone patch for low sexual desire in surgically menopausal women: a randomized trial
Buster, J. E., Kingsberg, S. A., Aguirre, O., Brown, C., Breaux, J. G., Buch, A., Rodenberg, C. A., Wekselman, K., & Casson, P. (2005) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000158103.27672.0d · Cited by 433
Randolph, J. F., Sowers, M., Gold, E. B., Mohr, B. A., Luborsky, J., Santoro, N., McConnell, D. S., Finkelstein, J. S., Korenman, S. G., Matthews, K. A., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020777 · Cited by 365 · cited 1×
“In more than 2000 perimenopausal women enrolled in the Study of Women’s Health Across the Nation (SWAN), total T and SHBG levels did not differ between African-American and Caucasian women (28).”
BackgroundLaughlin, G. A., Barrett-Connor, E., Kritz-Silverstein, D., & von Mühlen, D. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.2.6405 · Cited by 347 · cited 5×
“factor in late postmenopausal women (8, 9).”
BackgroundMethodResultInfluentialBurger, H. G. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.8.2832 · Cited by 341
Miller, K. K., Rosner, W., Lee, H., Hier, J., Sesmilo, G., Schoenfeld, D., Neubauer, G., & Klibanski, A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030680 · Cited by 301
Judd, H. L., Lucas, W. E., & Yen, S. S. C. (1974) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(74)90490-6 · Cited by 261 · cited 1×
“pausal women, with a 50% decline after oophorectomy (23)”
BackgroundCorrelates of Circulating Androgens in Mid-Life Women: The Study of Women’s Health Across the Nation
Santoro, N., Torrens, J., Crawford, S., Allsworth, J. E., Finkelstein, J. S., Gold, E. B., Korenman, S., Lasley, W. L., Luborsky, J. L., McConnell, D., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2063 · Cited by 246
(1981) · PubMed · Cited by 235
The climacteric ovary as a functional gonadotropin-driven androgen-producing gland.
Adashi, E. Y. (1994) · Fertility and Sterility · doi:10.1016/s0015-0282(16)56810-1 · Cited by 214
The Postmenopausal Ovary Is Not a Major Androgen-Producing Gland
Couzinet, B., Meduri, G., Lecce, M. G., Young, J., Brailly, S., Loosfelt, H., Milgrom, E., & Schaison, G. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.10.7900 · Cited by 211 · cited 1×
“Exogenous corticosteroids have been shown in small studies of premenopausal (19, 20) and postmenopausal (21) women to lower T levels by decreasing both adrenal androgen production and ovarian steroidogenesis through multiple inhibitory effects on the hypothalamic-pituitary-adrenal and hypothalamic-pituitary-ovarian ax…”
BackgroundGoodman-Gruen, D., & Barrett-Connor, E. (2000) · Diabetes Care · doi:10.2337/diacare.23.7.912 · Cited by 203
Body Composition and Endocrine Function in Women with Acquired Immunodeficiency Syndrome Wasting1
Grinspoon, S., Corcoran, C., Miller, K., Biller, B. M. K., Askari, H., Wang, E., Hubbard, J., Anderson, E. J., Basgoz, N., Heller, H. M., et al. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.5.3907 · Cited by 201
Sinha-Hikim, I., Arver, S., Beall, G., Shen, R., Guerrero, M., Sattler, F., Shikuma, C., Nelson, J. C., Landgren, B.-M., Mazer, N. A., et al. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.4.4718 · Cited by 187 · cited 7×
“Total T concentrations were measured by RIA using iodinated T as a tracer (13), which was validated against liquid chromatographytandem mass spectrometry (LC-MS/MS), as described previously (14).”
BackgroundMethodResultInfluentialSelf-citationKalish, G. M., Barrett-Connor, E., Laughlin, G. A., & Gulanski, B. I. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021375 · Cited by 156
Body Composition and Endocrine Function in Women with Acquired Immunodeficiency Syndrome Wasting
Grinspoon, S. K. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.5.1332 · Cited by 141
Effect of Postmenopausal Estrogen Replacement on Circulating Androgens
Casson, P. (1997) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(97)00538-3 · Cited by 139 · cited 1×
“and calculated free T decreased with estrogen use (24, 25) but differ from studies in which only the calculated free T declined (26, 27).”
ResultSinha‐Hikim, I. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.4.1312 · Cited by 126
Androgen Deficiency in Women with Hypopituitarism1
Miller, K. K., Sesmilo, G., Schiller, A., Schoenfeld, D., Burton, S., & Klibanski, A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7246 · Cited by 110 · cited 1×
“The levels we observed are lower than those seen in premenopausal women but higher than those seen in women with pituitary disease (36) and HIV (13, 37, 38).”
ResultLaughlin, G. A., Barrett-Connor, E., Kritz-Silverstein, D., & von Mühlen, D. (2000) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-200007000-00020 · Cited by 93
Androgen Deficiency in Women with Hypopituitarism
Miller, K. K. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.2.561 · Cited by 83
Longitudinal changes in dehydroepiandrosterone concentrations in men and women
Nafziger, A. N., Bowlin, S. J., Jenkins, P. L., & Pearson, T. A. (1998) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(98)90181-0 · Cited by 82
Exogenous Estrogen and Endogenous Sex Hormones
Tazuke, S., Khaw, K.-T., & Barrett-Connor, E. (1992) · MEDICINE · doi:10.1097/00005792-199201000-00004 · Cited by 78 · cited 1×
“and calculated free T decreased with estrogen use (24, 25) but differ from studies in which only the calculated free T declined (26, 27).”
ResultWAJCHENBERG, B. L., ACHANDO, S. S., OKADA, H., CZERESNIA, C. E., PEIXOTO, S., LIMA, S. S., & GOLDMAN, J. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-63-5-1204 · Cited by 76 · cited 1×
“Exogenous corticosteroids have been shown in small studies of premenopausal (19, 20) and postmenopausal (21) women to lower T levels by decreasing both adrenal androgen production and ovarian steroidogenesis through multiple inhibitory effects on the hypothalamic-pituitary-adrenal and hypothalamic-pituitary-ovarian ax…”
BackgroundEffects of Testosterone Replacement in Human Immunodeficiency Virus-Infected Women with Weight Loss
Choi, H. H., Gray, P. B., Storer, T. W., Calof, O. M., Woodhouse, L., Singh, A. B., Padero, C., Mac, R. P., Sinha-Hikim, I., Shen, R., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1677 · Cited by 76 · cited 3×
“997 between the RIA and LC-MS/MS measurements (14).”
BackgroundMethodSelf-citationEstrogen replacement therapy: effects on the endogenous androgen milieu
Simon, J. A. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(02)02986-2 · Cited by 74 · cited 1×
“and calculated free T decreased with estrogen use (24, 25) but differ from studies in which only the calculated free T declined (26, 27).”
ResultMiller, K. K. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.6.7610 · Cited by 70
Gower, B. A., & Nyman, L. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.12.7009 · Cited by 70 · cited 1×
“and calculated free T decreased with estrogen use (24, 25) but differ from studies in which only the calculated free T declined (26, 27).”
ResultMaturana, M. A., & Spritzer, P. M. (2002) · Metabolism · doi:10.1053/meta.2002.29997 · Cited by 56
Androgen Supplementation in Older Women: Too Much Hype, Not Enough Data
Padero, M. C. M., Bhasin, S., & Friedman, T. C. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50273.x · Cited by 54 · cited 3×
“There is growing evidence of improvement in some domains of sexual function in response to T therapy in women who have had oophorectomy (41–43), but data are lacking on the effects of T supplementation in late postmenopausal women on these and other outcomes, including muscle, bone, and cognition (10).”
BackgroundSelf-citationSerum levels of gonadotrophins and steroid hormones in the post-menopause and later life
Rozenberg, S., Bosson, D., Peretz, A., Caufriez, A., & Robyn, C. (1988) · Maturitas · doi:10.1016/0378-5122(88)90024-2 · Cited by 50 · cited 1×
“with low sensitivity and poor reliability or included small numbers of women over 65 yr (6, 7).”
BackgroundEndocrine Function of the Postmenopausal Ovary
Longcope, C. (2001) · Journal of the Society for Gynecologic Investigation · doi:10.1016/s1071-5576(00)00114-3 · Cited by 40
Javanbakht, M., Singh, A. B., Mazer, N. A., Beall, G. N., Sinha‐Hikim, I., Shen, R., & Bhasin, S. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6701 · Cited by 30 · cited 2×
“Specific risk factors for lower testosterone (T) levels in younger women include bilateral oophorectomy, estrogen use, corticosteroid use, adrenal or pituitary disease, and HIV infection (2).”
ResultSelf-citationThe effects of dexamethasone on plasma free androgens during the normal menstrual cycle
Kim, M. H., Rosenfield, R. L., & Dupon, C. (1976) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(76)90688-8 · Cited by 25 · cited 1×
“Exogenous corticosteroids have been shown in small studies of premenopausal (19, 20) and postmenopausal (21) women to lower T levels by decreasing both adrenal androgen production and ovarian steroidogenesis through multiple inhibitory effects on the hypothalamic-pituitary-adrenal and hypothalamic-pituitary-ovarian ax…”
BackgroundFemale Androgen Deficiency Syndrome—An Unproven Hypothesis
Bhasin, S. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1328 · Cited by 21 · cited 1×
“T therapy use in women of this age group is untested and requires clarification of the risk to benefit ratio, target population, and desirable T level before such studies are conducted (10, 44, 45).”
BackgroundSelf-citationJavanbakht, M. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.7.2395 · Cited by 16
Research works printed but not linked: 2
- Miller, 2001, Androgen deficiency in women., J Clin Endocrinol Metab, 86, 2395
- 2004, Testosterone and aging: clinical research directions/Committee on Assessing the Need for Clinical Trials of Testosterone Replacement Therapy/Board on Health Sciences Policy
Cited by
Endogenous Hormones and Breast Cancer Collaborative Group (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.254 · Cited by 391
“…of data from studies contributing to this collaboration (Laughlin et al, 2000) and others (Judd et al, 1974a; Vermeulen, 1976; Davison et al, 2005; Cappola et al, 2007; Fogle et al, 2007; McTiernan et al, 2008) have shown that postmenopausal women who have had a bilateral ovariectomy have lower…”
BackgroundGlobal Consensus Position Statement on the Use of Testosterone Therapy for Women
Davis, S. R., Baber, R., Panay, N., Bitzer, J., Perez, S. C., Islam, R. M., Kaunitz, A. M., Kingsberg, S. A., Lambrinoudaki, I., Liu, J., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-01603 · Cited by 270
Daniell, H. W. (2008) · The Journal of Pain · doi:10.1016/j.jpain.2007.08.005 · Cited by 263
Rothman, M. S., Carlson, N. E., Xu, M., Wang, C., Swerdloff, R., Lee, P., Goh, V. H. H., Ridgway, E. C., & Wierman, M. E. (2011) · Steroids · doi:10.1016/j.steroids.2010.10.010 · Cited by 248
Sex Differences in Muscle Wasting
Anderson, L. J., Liu, H., & Garcia, J. M. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-70178-3_9 · Cited by 219
Metadata
- Authors
- Cappola, A. R., Ratcliffe, S. J., Bhasin, S., Blackman, M. R., Cauley, J., Robbins, J., Zmuda, J. M., Harris, T., & Fried, L. P.
- Affiliations
- University of Pennsylvania (US)
- Boston University (US)
- National Institutes of Health (US)
- University of Pittsburgh (US)
- University of California Davis Medical Center (US)
- Johns Hopkins University (US)
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2006-11-07
- Volume
- 92
- Issue
- 2
- Pages
- 509-516
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1985476608
- Cited by
- 67
- References
- 50
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 1 · 2023: 4 · 2022: 3 · 2021: 2 · 2020: 4 · 2019: 6 · 2017: 4 · 2016: 2 · 2015: 2 · 2013: 5 · 2012: 6
- FWCI
- 2.27
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Columbia Academic Commons (Columbia University)
- Funders
- Pfizer
- National Institutes of Health (n01hc085079-024, n01hc015103-009, n01hc085086-022, n01hc035129-010)
- National Institute on Aging (N01HC85079, N01 HC‐15103, N01‐HC‐35129, K23AG19161, N01‐HC‐85086, K23AG019161)
- National Heart, Lung, and Blood Institute (N01HC15103, N01 HC85086, N01-HC-85079 through N01-HC-85086, N01-HC85079, N01HC35129)
- National Center for Complementary and Alternative Medicine
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- serum testosterone, free testosterone, total testosterone, postmenopausal women, older women, age-related decline, bilateral oophorectomy, estrogen therapy, corticosteroid use, obesity, body mass index, racial differences
- MeSH terms
- Aged, Aged, 80 and over, Aging, Cross-Sectional Studies, Female, Humans, Hypogonadism, Obesity, Ovariectomy, Ovary, Predictive Value of Tests, Risk Factors, Testosterone, Estrogen Replacement Therapy, Body Mass Index, Prevalence, Multivariate Analysis, Age Distribution, Postmenopause, Nonlinear Dynamics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.